Sunday 11 October 2026 Export all CME data to Excel Powerpack

CME Group Inc.

CME Financial Financial Data & Stock Exchanges

CME Group Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.5 billion, up 6.37% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS grew 2.85%, free cash flow fell 11.2% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

280.56 4.12 +1.49%
Market cap
$99.4B
P/E
23.6×
Fwd P/E
21.7×
Dividend yield
1.37%
F-score
4/9
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

CME Group Inc. (CME) SEC filings, changes and red flags

Red flags

Filings

Form Period Filed What it reports Flags
8-K Sep 24, 2026 5.03 Amendments to the articles or bylaws; change in fiscal year
8-K Sep 9, 2026 5.02 Departure or appointment of directors or officers; 9.01 Financial statements and exhibits Officer departure
8-K Aug 11, 2026 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-Q Jun 30, 2026 P1I2: 8 added · 6 removed · 32 modified
P2I1A: no material changes, the filing says
8-K Jul 22, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jun 16, 2026 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Jun 9, 2026 5.07 Submission of matters to a vote of security holders
8-K May 14, 2026 5.07 Submission of matters to a vote of security holders
8-K Apr 22, 2026 1.01 Entry into a material definitive agreement; 9.01 Financial statements and exhibits
10-Q Mar 31, 2026
8-K Apr 22, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-K Dec 31, 2025 1: 33 added · 28 removed · 58 modified
1A: 10 added · 44 modified
7: 13 added · 11 removed · 35 modified
8-K Feb 4, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Feb 2, 2026 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-Q Sep 30, 2025
8-K Oct 22, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Sep 9, 2025 5.02 Departure or appointment of directors or officers
10-Q Jun 30, 2025
10-K Dec 31, 2024

From the company’s filings on sec.gov. Red flags are raised by rules over the filings’ own data and text; they are not investment advice.